AGA Medical pioneered the repair of congenital and structural heart defects using non-surgical techniques for treating a wide range of these life threatening diseases.
 Atrial Septal Defects
Atrial Septal Defects (ASD) are caused by incomplete growth of the tissue wall (septum) that separates the upper chambers of the heart (atria).
Patent Foramen Ovale
A Patent Foramen Ovale (PFO) is a small opening in the wall (septum) between the left atrium and the right atrium.
|
Ventricular Septal Defects
Ventricular Septal Defects (VSD) are caused by incomplete growth of the tissue wall (septum) that separates the lower chambers of the heart (ventricles).
Vascular Occlusion
Blood vessel occlusion (closure) may be used to reduce or eliminate blood flow to a targeted organ, or to reroute blood flow through other vessels.
|
For you to receive accurate information on Atrial Septal Defects (ASD) and Patent Foramen Ovale (PFO), we need you to specify whether you reside within the United States or outside the United States. Procedure options vary depending on where you reside. Please click on whether you reside in the United States or Outside the United States.
Current Clinical Trials
 |
Respect Trial - United States
AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use. |
|
|
 |
Premium Trial - United States
AMPLATZER® PFO Occluder - Notice of Availability - Caution: Investigational device. Limited by Federal (U.S.) law to investigational use. |
|
|
 |
Prima Trial - Europe and Canada
AMPLATZER® PFO Occluder - Notice of Availability: Contact AGA Medical for more information on Prima Trial approvals for each country. |